BLPH - Bellerophon Therapeutics GAAP EPS of $0.27 revenue of $5.64M May, 15 2023 05:31 PM Bellerophon Therapeutics Inc. 2023-05-15 17:31:26 ET Bellerophon Therapeutics press release ( NASDAQ: BLPH ): Q1 GAAP EPS of $0.27. Revenue of $5.64M. For further details see: Bellerophon Therapeutics GAAP EPS of $0.27, revenue of $5.64M